Search Page

1

Cite

Share

PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.

Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD. Tartaglia M, et al. Among authors: kalidas k. Am J Hum Genet. 2002 Jun;70(6):1555-63. doi: 10.1086/340847. Epub 2002 May 1. Am J Hum Genet. 2002. PMID: 11992261 Free PMC article.

Cite

Share

2

Cite

Share

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.

Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD. Tartaglia M, et al. Among authors: kalidas k. Nat Genet. 2001 Dec;29(4):465-8. doi: 10.1038/ng772. Nat Genet. 2001. PMID: 11704759

Cite

Share

3

Cite

Share

Medical marijuana in neurology.

Benbadis SR, Sanchez-Ramos J, Bozorg A, Giarratano M, Kalidas K, Katzin L, Robertson D, Vu T, Smith A, Zesiewicz T. Benbadis SR, et al. Among authors: kalidas k. Expert Rev Neurother. 2014 Dec;14(12):1453-65. doi: 10.1586/14737175.2014.985209. Expert Rev Neurother. 2014. PMID: 25427150 Review.

Cite

Share

4

Cite

Share

Inherited metabolic disorders and cerebral infarction.

Kalidas K, Behrouz R. Kalidas K, et al. Expert Rev Neurother. 2008 Nov;8(11):1731-41. doi: 10.1586/14737175.8.11.1731. Expert Rev Neurother. 2008. PMID: 18986243 Review.

Cite

Share

5

Cite

Share

Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications.

Goadsby PJ, Blumenfeld AM, Lipton RB, Dodick DW, Kalidas K, M Adams A, Jakate A, Liu C, Szegedi A, Trugman JM. Goadsby PJ, et al. Among authors: kalidas k. Cephalalgia. 2021 Apr;41(5):546-560. doi: 10.1177/0333102420970523. Epub 2020 Nov 26. Cephalalgia. 2021. PMID: 33241721 Free PMC article. Clinical Trial.

Cite

Share

6

Cite

Share

Absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndrome.

Ion A, Tartaglia M, Song X, Kalidas K, van der Burgt I, Shaw AC, Ming JE, Zampino G, Zackai EH, Dean JC, Somer M, Parenti G, Crosby AH, Patton MA, Gelb BD, Jeffery S. Ion A, et al. Among authors: kalidas k. Hum Genet. 2002 Oct;111(4-5):421-7. doi: 10.1007/s00439-002-0803-6. Epub 2002 Aug 24. Hum Genet. 2002. PMID: 12384786 Review.

Cite

Share

7

Cite

Share

Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine.

Martinez JM, Hindiyeh N, Anglin G, Kalidas K, Hodsdon ME, Kielbasa W, Moser BA, Pearlman EM, Garces S. Martinez JM, et al. Among authors: kalidas k. Cephalalgia. 2020 Aug;40(9):978-989. doi: 10.1177/0333102420920642. Epub 2020 Apr 27. Cephalalgia. 2020. PMID: 32340471 Free PMC article.

Cite

Share

8

Cite

Share

Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine.

Doty EG, Krege JH, Jin L, Raskin J, Halker Singh RB, Kalidas K. Doty EG, et al. Among authors: kalidas k. Cephalalgia. 2019 Oct;39(12):1569-1576. doi: 10.1177/0333102419859313. Epub 2019 Jul 3. Cephalalgia. 2019. PMID: 31266353 Free PMC article. Clinical Trial.

Cite

Share

9

Cite

Share

Triptan education and improving knowledge for optimal migraine treatment: an observational study.

Baron EP, Markowitz SY, Lettich A, Hastriter E, Lovell B, Kalidas K, Dodick DW, Schwedt TJ; American Headache Society Headache Fellows Research Consortium. Baron EP, et al. Among authors: kalidas k. Headache. 2014 Apr;54(4):686-97. doi: 10.1111/head.12286. Epub 2014 Feb 12. Headache. 2014. PMID: 24520930 Free PMC article.

Cite

Share

10

Cite

Share

The natural history of Noonan syndrome: a long-term follow-up study.

Shaw AC, Kalidas K, Crosby AH, Jeffery S, Patton MA. Shaw AC, et al. Among authors: kalidas k. Arch Dis Child. 2007 Feb;92(2):128-32. doi: 10.1136/adc.2006.104547. Epub 2006 Sep 21. Arch Dis Child. 2007. PMID: 16990350 Free PMC article.

Cite

Share